BORTEZOMIB

Product NDC
55150-337
11-digit product format
551500337
Labeler code
55150
Product ID
55150-337_107c9155-9130-4202-b2e4-4c7732561420
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
BORTEZOMIB
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Labeler
Eugia US LLC
Application
ANDA212825
Marketing category
ANDA
Marketing start
2022-05-02
Substance
BORTEZOMIB
Active strength
3.5 mg/1
Pharmacologic classes
Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
BORTEZOMIB
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BORTEZOMIB3.5 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii69G8BD63PP
Rxcui402243

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b069d653-565d-b331-cf82-116aa266aee9Product name420260317
987023d7-918d-4465-be3c-f3f8f784679bProduct name120250318
2cff6375-aa9a-4194-a1db-33f6ed6564f1Product name120230322
f8ade071-6be1-4cb3-a390-e8ba41353f9bProduct name120230322
c3c5823c-3bc3-46c2-bc6a-295b30affa78Product name120230113
6429b384-c989-4e27-bc69-c5e1c7dc2e31Product name120200304
71c1111b-030c-4ada-94cb-bf623cfad8ecProduct name120180108

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
55150-337-01BORTEZOMIB1 in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,13
55150-337-01BORTEZOMIB1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,13
55150-337-02BORTEZOMIB1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,11
55150-337-02BORTEZOMIB1 in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,11

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
55150-337-01EA - Each55150-337d603370e-e5b0-45a5-bc14-7154e28edc3212022-06-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
55150-337BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [EUGIA US LLC]3Current NDC, Legacy NDC, 2 package rows20241208_76c7c3a5-fd2f-403f-85fd-65a64538eee7.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
402243bortezomib 3.5 MG InjectionPSN76c7c3a5-fd2f-403f-85fd-65a64538eee73
402243bortezomib 3.5 MG InjectionSCD76c7c3a5-fd2f-403f-85fd-65a64538eee73
402243bortezomib 3.5 MG InjectionPSNed526447-a4fe-403b-8f08-21ce1b2fa8b71
402243bortezomib 3.5 MG InjectionSCDed526447-a4fe-403b-8f08-21ce1b2fa8b71

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
55150-337-01551500337011 VIAL, SINGLE-DOSE in 1 CARTON (55150-337-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE2022-05-020000-00-00NoNoCurrent
55150-337-02551500337021 VIAL, SINGLE-DOSE in 1 CARTON (55150-337-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE2022-05-02NoNoHistorical